HIGHLIGHTS
- who: Shiguang Zhao from the Peoples' Friendship University of Russia, Russia have published the Article: Phase I/II trial of local interstitial chemotherapy with arsenic trioxide in patients with newly diagnosed glioma, in the Journal: (JOURNAL)
- what: The results in this trial demonstrated that adjuvant ATO may result in mild to moderate non-hematological toxicities.
- future: Before clinical application further studies are required to improve and develop the method of ATO local interstitial chemotherapy to explore the safety and efficacy for patients with recurrent glioma and to investigate of the therapeutic effects of . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.